Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology, By Pathogen, By End Use, By Region, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Pathogen
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Antimicrobial Resistance Diagnostics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increase in risk of developing drug-resistant bacterial infections
    • 3.2.1.2. Introduction of novel technologies to diagnose AMR infections
    • 3.2.1.3. Favorable government initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Presence of stringent rules and regulations pertaining to diagnostics
• 3.3. Antimicrobial Resistance Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Antimicrobial Resistance Diagnostics Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Antimicrobial Resistance Diagnostics Market: Technology Movement Analysis
• 4.3. Antimicrobial Resistance Diagnostics Market by Technology Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Microbiology Culture
  • 4.5.1. Microbiology Culture Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Immunoassay
  • 4.6.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. PCR
    • 4.6.2.1. PCR Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. NGS
    • 4.6.3.1. NGS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Mass Spectrometry
    • 4.6.4.1. Mass Spectrometry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.5. Rapid & Point of Care
    • 4.6.5.1. Rapid & Point of Care Assays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Antimicrobial Resistance Diagnostics Market: Pathogen Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Antimicrobial Resistance Diagnostics Market: Pathogen Movement Analysis
• 5.3. Antimicrobial Resistance Diagnostics Market by Pathogen Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Drug Resistant Streptococcus Pneumoniae (DRSP)
  • 5.5.1. Drug Resistant Streptococcus Pneumoniae (DRSP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Drug Resistant Campylobacter (DRC)
  • 5.6.1. Drug Resistant Campylobacter (DRC) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Clostridium Difficile (CD)
  • 5.7.1. Clostridium Difficile (CD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Methicillin Resistant Staphylococcus Aureus (MRSA)
  • 5.8.1. Methicillin Resistant Staphylococcus Aureus (MRSA) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Drug Resistant Neisseria Gonorrhoeae (DRNG)
  • 5.9.1. Drug Resistant Neisseria Gonorrhoeae (DRNG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Drug Resistant Salmonella (DRNTS)
  • 5.10.1. Drug Resistant Salmonella (DRNTS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Others
  • 5.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Antimicrobial Resistance Diagnostics Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Antimicrobial Resistance Diagnostics Market: End Use Movement Analysis
• 6.3. Antimicrobial Resistance Diagnostics Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Diagnostic Laboratories
  • 6.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Pharmaceutical & Biotechnology Companies
  • 6.7.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Antimicrobial Resistance Diagnostics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.9. Portugal
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework/ reimbursement structure
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Portugal market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.10. Turkey
    • 7.4.10.1. Key country dynamics
    • 7.4.10.2. Regulatory framework/ reimbursement structure
    • 7.4.10.3. Competitive scenario
    • 7.4.10.4. Turkey market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.11. Switzerland
    • 7.4.11.1. Key country dynamics
    • 7.4.11.2. Regulatory framework/ reimbursement structure
    • 7.4.11.3. Competitive scenario
    • 7.4.11.4. Switzerland market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.12. Belgium
    • 7.4.12.1. Key country dynamics
    • 7.4.12.2. Regulatory framework/ reimbursement structure
    • 7.4.12.3. Competitive scenario
    • 7.4.12.4. Belgium market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.13. Netherlands
    • 7.4.13.1. Key country dynamics
    • 7.4.13.2. Regulatory framework/ reimbursement structure
    • 7.4.13.3. Competitive scenario
    • 7.4.13.4. Netherlands market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.14. ROE
    • 7.4.14.1. Key country dynamics
    • 7.4.14.2. Regulatory framework/ reimbursement structure
    • 7.4.14.3. Competitive scenario
    • 7.4.14.4. ROE market estimates and forecasts 2021 to 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.7. Malaysia
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.8. Indonesia
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework/ reimbursement structure
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Indonesia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.9. Vietnam
    • 7.5.9.1. Key country dynamics
    • 7.5.9.2. Regulatory framework/ reimbursement structure
    • 7.5.9.3. Competitive scenario
    • 7.5.9.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.10. Rest of APAC
    • 7.5.10.1. Key country dynamics
    • 7.5.10.2. Regulatory framework/ reimbursement structure
    • 7.5.10.3. Competitive scenario
    • 7.5.10.4. ROE market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.3. Colombia
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.4. Peru
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Peru market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.5. Ecuador
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Ecuador market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.6. Rest of Latin America
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Rest of Latin America market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Recent Developments & Impact Analysis by Key Market Participants
• 8.3. Company Market Share Analysis, 2025
• 8.4. Key Company Profiles
  • 8.4.1. bioMerieux
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. F. Hoffmann - La Roche Ltd
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Abbott
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. BD
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Danaher
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Accelerate Diagnostics, Inc.
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Molsid
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Vela Diagnostics
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Visby Medical, Inc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Hologic, Inc.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. OpGen.
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Seegene Inc
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. EliTechGroup
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives
  • 8.4.14. CERTEST BIOTEC
    • 8.4.14.1. Company overview
    • 8.4.14.2. Financial performance
    • 8.4.14.3. Product benchmarking
    • 8.4.14.4. Strategic initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 4 Global antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 5 Global antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 6 North America Antimicrobial Resistance Diagnostics market, by region, 2021 - 2033 (USD Million)
• Table 7 North America antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 8 North America antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 9 North America antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 10 US antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 11 US antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 12 US antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 13 Mexico antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 14 Mexico antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 15 Mexico antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 16 Canada antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 17 Canada antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 18 Canada antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 19 Europe antimicrobial resistance diagnostics market, by country, 2021 - 2033 (USD Million)
• Table 20 Europe antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 21 Europe antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 22 Europe antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 23 UK antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 24 UK antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 25 UK antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 26 Germany antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 27 Germany antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 28 Germany antimicrobial resistance diagnostics market, by End Use 2021 - 2033 (USD Million)
• Table 29 France antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 30 France antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 31 France antimicrobial resistance diagnostics market, by End Use 2021 - 2033 (USD Million)
• Table 32 Italy antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 33 Italy antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 34 Italy antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 35 Spain antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 36 Spain antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 37 Spain antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 38 Denmark antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 39 Denmark antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 40 Denmark antimicrobial resistance diagnostics market, by End Use 2021 - 2033 (USD Million)
• Table 41 Norway antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 42 Norway antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 43 Norway antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 44 Sweden antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 45 Sweden antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 46 Sweden antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 47 Portugal antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 48 Portugal antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 49 Portugal antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 50 Belgium antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 51 Belgium antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 52 Belgium antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 53 Turkey antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 54 Turkey antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 55 Turkey antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 56 Switzerland antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 57 Switzerland antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 58 Switzerland antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 59 Netherlands antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 60 Netherlands antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 61 Netherlands antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 62 ROE antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 63 ROE antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 64 Asia Pacific antimicrobial resistance diagnostics market, by country, 2021 - 2033 (USD Million)
• Table 65 Asia Pacific antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 66 Asia Pacific antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 67 Asia Pacific antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 68 Japan antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 69 Japan antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 70 Japan antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 71 China antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 72 China antimicrobial resistance diagnostics market, by Pathogen 2021 - 2033 (USD Million)
• Table 73 China antimicrobial resistance diagnostics market, by End Use 2021 - 2033 (USD Million)
• Table 74 India antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 75 India antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 76 India antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 77 Australia antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 78 Australia antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 79 Australia antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 80 South Korea antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 81 South Korea antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 82 South Korea antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 83 Thailand antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 84 Thailand antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 85 Thailand antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 86 Malaysia antimicrobial resistance diagnostics market, by Product, 2021 - 2033 (USD Million)
• Table 87 Malaysia antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 88 Malaysia antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 89 Indonesia antimicrobial resistance diagnostics market, by Product, 2021 - 2033 (USD Million)
• Table 90 Indonesia antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 91 Indonesia antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 92 Vietnam antimicrobial resistance diagnostics market, by Product, 2021 - 2033 (USD Million)
• Table 93 Vietnam antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 94 Vietnam antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 95 Rest of APAC antimicrobial resistance diagnostics market, by Product, 2021 - 2033 (USD Million)
• Table 96 Rest of APAC antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 97 Rest of APAC antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 98 Latin America antimicrobial resistance diagnostics market, by country, 2021 - 2033 (USD Million)
• Table 99 Latin America antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 100 Latin America antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 101 Latin America antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 102 Brazil antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 103 Brazil antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 104 Brazil antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 105 Argentina antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 106 Argentina antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 107 Argentina antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 108 Colombia antimicrobial resistance diagnostics market, by Product, 2021 - 2033 (USD Million)
• Table 109 Colombia antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 110 Colombia antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 111 Peru antimicrobial resistance diagnostics market, by Product, 2021 - 2033 (USD Million)
• Table 112 Peru antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 113 Peru antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 114 Ecuador antimicrobial resistance diagnostics market, by Product, 2021 - 2033 (USD Million)
• Table 115 Ecuador antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 116 Ecuador antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 117 Middle East & Africa antimicrobial resistance diagnostics market, by country, 2021 - 2033 (USD Million)
• Table 118 Middle East & Africa antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 119 Middle East & Africa antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 120 Middle East & Africa antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 121 South Africa antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 122 South Africa antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 123 South Africa antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 124 Saudi Arabia antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 125 Saudi Arabia antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 126 Saudi Arabia antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 127 UAE antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 128 UAE antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 129 UAE antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million)
• Table 130 Kuwait antimicrobial resistance diagnostics market, by Technology, 2021 - 2033 (USD Million)
• Table 131 Kuwait antimicrobial resistance diagnostics market, by Pathogen, 2021 - 2033 (USD Million)
• Table 132 Kuwait antimicrobial resistance diagnostics market, by End Use, 2021 - 2033 (USD Million

List of Figures

• Fig 1 Information procurement
• Fig 2 Primary research pattern
• Fig 3 Market research approaches
• Fig 4 Value chain-based sizing & forecasting
• Fig 5 Market formulation & validation
• Fig 6 Antimicrobial Resistance Diagnostics market segmentation
• Fig 7 Market driver analysis (current & future impact)
• Fig 8 Market restraint analysis (current & future impact)
• Fig 9 SWOT analysis, by factor (political & legal, economic and technological)
• Fig 10 Porter's five forces analysis
• Fig 11 Antimicrobial resistance diagnostics market, Technology outlook key takeaways 2025 & 2033 (USD Million)
• Fig 12 Antimicrobial resistance diagnostics market: Pathogen movement analysis 2025 & 2033 (USD Million)
• Fig 13 Antimicrobial resistance diagnostics market: end use movement analysis 2025 & 2033 (USD Million)
• Fig 14 Microbiology Culture market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 15 Immunoassay market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 16 PCR market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 17 NGS market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 18 Mass Spectrometry market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 19 Rapid & Point of Care market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 20 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 21 Drug Resistant Streptococcus Pneumoniae market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 22 Drug Resistant Campylobacter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 23 Clostridium Difficile market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 24 Methicillin Resistant Staphylococcus Aureus market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 25 Drug Resistant Neisseria Gonorrhoeae market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 26 Drug Resistant Salmonella market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 27 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 28 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 29 Diagnostic Laboratories market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 30 Pharmaceutical & Biotechnology Companies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 31 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 32 North America antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 33 US antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 34 US antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 35 Canada antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 36 Mexico antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 37 Europe antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 38 UK antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 39 Germany antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 40 France antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 41 Spain antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 42 Italy antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 43 Belgium antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 44 Portugal antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 45 Netherlands antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million
• Fig 46 Turkey antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million
• Fig 47 Switzerland antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million
• Fig 48 Asia Pacific antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 49 China antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 50 Japan antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 51 India antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 52 South Korea antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 53 Australia antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 54 Thailand antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 55 Malaysia antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 56 Indonesia antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 57 Vietnam antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 58 ROE antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 59 Latin America antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 60 Brazil antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 61 Argentina antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 62 Peru antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 63 Colombia antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 64 Ecuador antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 65 Middle East and Africa antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 66 South Africa antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 67 Saudi Arabia antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 68 UAE antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig 69 Kuwait antimicrobial resistance diagnostics market estimates and forecasts, 2021 - 2033 (USD Million
• Fig 70 List of key emerging company's/Allergen disruptors/innovators